Literature DB >> 17627633

Differences of HBV genotypes and hepatocellular carcinoma in Asian countries.

Etsuro Orito1, Masashi Mizokami.   

Abstract

Hepatitis B virus (HBV) genotype B (HBV B) and genotype C (HBV C) are prevalent in Asia. Recently HBV B has been classified into two subtypes, HBV Ba, which is ubiquitous in Asia, and HBV Bj specific to Japan. However, little is known about etiological, virological and clinical differences among patients who have various genotypes and who developed hepatocellular carcinoma (HCC). We investigated the relation of HBV subgenotype with etiological and clinical differences of HCC patients between Taiwan and Okinawa in Japan. HBV Bj may be associated with lower incidence of HCC and older development of HCC while HBV Ba or HBV C may be associated withhigher incidence of HCC and younger development of HCC. In addition, we demonstrated the relationship of the specific mutation of HBV, T1653 mutation in the core promoter region, with development of HCC in Japanese patients with HBV C. These data suggest that great differences exist among patients with HCC who are infected with different HBV genotypes or genotype-specific mutations.

Entities:  

Year:  2007        PMID: 17627633     DOI: 10.1111/j.1872-034X.2007.00101.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  9 in total

1.  Clinical relevance and public health significance of hepatitis B virus genomic variations.

Authors:  Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

2.  Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma.

Authors:  Lang Hu; Gang Chen; Hongping Yu; Xiaoqiang Qiu
Journal:  Hepatol Int       Date:  2010-01-29       Impact factor: 6.047

3.  Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.

Authors:  Yoshiyasu Karino; Joji Toyota; Hiromitsu Kumada; Yoshiaki Katano; Namiki Izumi; Haruhiko Kobashi; Michio Sata; Mitsuhiko Moriyama; Fumio Imazeki; Masayoshi Kage; Hiroki Ishikawa; Nobuyuki Masaki; Taku Seriu; Masao Omata
Journal:  Hepatol Int       Date:  2010-02-06       Impact factor: 6.047

Review 4.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

Review 5.  Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.

Authors:  Caecilia H C Sukowati; Korri E El-Khobar; Susan I Ie; Beatrice Anfuso; David H Muljono; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

6.  The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area.

Authors:  Naota Taura; Nobuyoshi Fukushima; Hiroshi Yastuhashi; Yuko Takami; Masataka Seike; Hiroshi Watanabe; Toshihiko Mizuta; Yutaka Sasaki; Kenji Nagata; Akinari Tabara; Yasuji Komorizono; Akinobu Taketomi; Shuichi Matsumoto; Tsutomu Tamai; Toyokichi Muro; Kazuhiko Nakao; Kunitaka Fukuizumi; Tatsuji Maeshiro; Osami Inoue; Michio Sata
Journal:  Med Sci Monit       Date:  2011-02

7.  Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients.

Authors:  Meisongzhu Yang; Gang Chen; Yiwu Dang; Dianzhong Luo
Journal:  Ups J Med Sci       Date:  2010-11       Impact factor: 2.384

8.  Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study.

Authors:  Wei Li; Dao-Ming Li; Kai Chen; Zheng Chen; Yang Zong; Hong Yin; Ze-Kuan Xu; Yi Zhu; Fei-Ran Gong; Min Tao
Journal:  BMC Cancer       Date:  2012-11-23       Impact factor: 4.430

9.  PreS1 Mutations Alter the Large HBsAg Antigenicity of a Hepatitis B Virus Strain Isolated in Bangladesh.

Authors:  Md Golzar Hossain; Md Muket Mahmud; K H M Nazmul Hussain Nazir; Keiji Ueda
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.